Cheque Drops

DRAGON PHARMA CHEQUE DROPS

Cheque Drops are typically found in tablet form, featuring a distinctive white color. Each tablet may be imprinted with a specific dosage strength. The drug is known for its potent androgenic properties.

DRUG COMPOSITION

Cheque Drops, also known as Mibolerone, is an oral steroid that contains the active ingredient mibolerone. It is a synthetic androgenic-anabolic steroid (AAS) designed for veterinary use but is not approved for human use.

PHARMACEUTICAL FORM

Cheque Drops are formulated as oral tablets, facilitating ease of administration. The tablets are specifically designed to allow for efficient absorption within the gastrointestinal tract.

PHARMACEUTICAL GROUP AND ATC CODE

Cheque Drops belong to the pharmacotherapeutic group of androgens. While not assigned an Anatomical Therapeutic Chemical (ATC) code for human use, it is classified under the subgroup of androgenic hormones.

PHARMACOLOGICAL PROPERTIES

Mibolerone, the active ingredient in Cheque Drops, is a derivative of nandrolone with strong androgenic properties. It exhibits anabolic effects, promoting muscle growth and increased aggression. Due to its potency, it is often used in veterinary settings to enhance aggression in certain animals.

PROFILE

• Chemical name: Estr-4-en-one,17-hydroxy-7,17-dimetyl-, (7alpha, 17beta)
• Chemical formula: C20H30O2
• Percentage of anabolic activity: 4100.00%
• Percentage of androgenic activity: 1600.00%
• Active half life: 2-4 hours
• Recommended dosage: 200-300 mcg/day
• Acne: yes
• Bloating (water retention): yes
• HBR: perhaps
• Hepatic toxicity: no
• Aromatization: yes

THERAPEUTICAL INDICATIONS

Cheque Drops are not intended for human therapeutic use. In veterinary medicine, they may be employed to modify behavior in certain animals. However, their use in animals is limited due to potential adverse effects.

DOSES AND METHOD OF ADMINISTRATION

Due to its potency, Cheque Drops are typically administered in very low doses. The dosing regimen, if used, should be carefully controlled, and administration is done orally. It is essential to consult with a healthcare professional or veterinarian regarding proper dosing.

CYCLE/STACKING

Cheque Drops are not commonly used in traditional anabolic steroid cycles. Given its strong androgenic nature, it may be employed briefly before athletic events to enhance aggression and competitive drive.

POST CYCLE THERAPY

Post-cycle therapy (PCT) is not applicable for Cheque Drops as they are not intended for extended use. If used, a careful evaluation of the risk-benefit ratio and potential adverse effects is crucial.

SIDE EFFECTS

Potential side effects of Cheque Drops may include androgenic effects such as increased aggression, irritability, and potential cardiovascular strain. Virilization is a concern in female users.

CONTRAINDICATIONS

Cheque Drops are contraindicated for use in humans due to their potent androgenic nature. They may lead to severe adverse effects and are not approved for therapeutic purposes.

OVERDOSE

Cases of acute overdose with Cheque Drops are rare, given its limited use. However, exceeding recommended doses may amplify adverse effects, warranting immediate medical attention.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE:

Extreme caution should be exercised if considering the use of Cheque Drops, given their potency and potential for adverse effects. Professional guidance is crucial to minimize risks.

INTERACTIONS WITH OTHER DRUGS

Information regarding potential drug interactions with Cheque Drops is limited. It is advisable to disclose all medications and supplements to healthcare professionals to prevent possible interactions.

PRESENTATION, PACKAGING

100 tablets in sachet.

STORAGE

Cheque Drops should be stored in a cool, dry place, away from direct sunlight. Adherence to recommended storage conditions is essential to maintain the stability of the drug.

DELIVERY TO THE USA

Cheque Drops is available for secure and discreet delivery to the USA through authorized supplier - Steroid.biz.

LEGAL STATUS

Cheque Drops are not approved for human use in many countries. Their possession, distribution, and use for non-veterinary purposes may be subject to legal restrictions. Compliance with local regulations is essential.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Dragon Pharma
Europe

EXTERNAL LINKS

• Mibolerone Wiki, wikipedia.org.